Ultralight Raises $9.3M Seed to Build AI-Native EHR Platform for Longevity and Personalized Medicine Clinics

Doctors aren’t short on data. They’re buried in it. Tabs stacked like bad habits, signals lost in the noise, and patients left wondering how “personalized care” still feels anything but. That gap between information and actual insight has been sitting there, unresolved, waiting for someone to treat it like the real problem. Ultralight walked straight into that gap and didn’t blink.

Ultralight, the NYC-based AI-native EHR built for longevity and personalized medicine clinics, just pulled in $9.3M across pre-seed and seed. The General Partnership led the round, with Wisdom Ventures, Anthemis, and Emerson Collective stepping in like they’ve seen this movie before and already know how it ends.

Sunita Mohanty and Pedro Tabio are not selling software, they’re compressing time. When your system can take labs, wearables, diagnostics, notes, and the usual avalanche of patient data and turn it into something a clinician can actually use before the coffee cools, you’re not improving workflow, you’re reclaiming it. 75 clinics already live, thousands waiting, and not a dollar burned on paid acquisition. That’s not luck, that’s signal.

Ultralight used to be Vibrant Practice, which feels fitting because this isn’t a pivot, it’s a refinement. Less noise, more clarity. The product didn’t change direction, it sharpened its edge. The “ultralight” name hits because that’s the promise. Take something heavy, complex, borderline unbearable, and make it feel like it belongs in the background, not the breaking point.

Here’s the part founders should sit with for a minute. They didn’t bolt AI onto an old system and call it innovation. They built around the reality that modern clinics are drowning in high frequency data and starving for usable insight. The so-called agentic layer isn’t a feature, it’s the whole play. Prep the visit, monitor the patient, surface what matters. Everything else is just UI dressing.

Investors didn’t lean in because healthcare needs another dashboard. They leaned in because Ultralight is positioning itself as the operating system for a category that’s expanding fast and thinking differently about care. Longevity clinics, functional medicine, concierge practices, all high touch, all data heavy, all underserved by legacy infrastructure that still thinks in billing codes instead of human outcomes.

There’s a rhythm here that’s hard to fake. Build something clinicians actually want to use, prove it in the wild, let demand stack up quietly, then raise with leverage. No theatrics, just traction doing the talking.

Sunita Mohanty and Pedro Tabio didn’t just raise capital. They tightened the feedback loop between data and decision making. And in a space where time is the most expensive currency in the room, that’s the kind of upgrade people feel immediately, even if they can’t quite explain why.